At what age can Clavam (amoxicillin-clavulanic acid) be started as a three times a day (tds) dose in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clavam (Amoxicillin-Clavulanate) Three Times Daily Dosing by Age

Clavam can be started as a three times daily (TDS) dose from birth onwards, with specific weight-based dosing beginning at ≥12 weeks of age for most infections. 1

Age-Specific TDS Dosing Guidelines

Infants and Young Children (Birth to 1 Year)

  • Standard dosing: 0.266 ml/kg of 125/31 suspension three times daily from birth 1
  • Alternative fixed dosing: 2.5 ml of 125/31 suspension three times daily for children birth to 1 year 1
  • For children ≥12 weeks with less severe infections: 20 mg/kg/day divided every 8 hours (TDS) 1
  • For children ≥12 weeks with more severe infections: 40 mg/kg/day divided every 8 hours (TDS) 1

Children 1-6 Years

  • Standard dosing: 5 ml of 125/31 suspension three times daily 1

Children 7-12 Years

  • Standard dosing: 5 ml of 250/62 suspension three times daily 1

Children 12-18 Years

  • Standard dosing: 1 tablet (250/125 mg) three times daily 1

High-Dose TDS Regimen for Resistant Infections

For severe infections or suspected resistant bacteria, a high-dose formulation providing 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate can be given in two divided doses (not TDS), which is preferred over TDS dosing for resistant pathogens. 1 This formulation was specifically developed to provide better coverage against penicillin-resistant Streptococcus pneumoniae. 2

Important Clinical Considerations

When to Use TDS vs BID Dosing

  • TDS (three times daily) dosing is the traditional regimen and remains appropriate for standard infections 1
  • BID (twice daily) dosing has been shown to be equally effective as TDS dosing with improved compliance and potentially fewer gastrointestinal side effects due to lower total daily clavulanate exposure 3, 4
  • Clinical trials demonstrate that once or twice daily amoxicillin-clavulanate produces comparable clinical cure rates, recurrence rates, and compliance compared to three times daily dosing 3

Common Pitfalls to Avoid

  • Do not extrapolate term infant dosing to premature infants due to immature renal function and risk of drug accumulation 5
  • Diarrhea occurs more frequently with TDS dosing (22.6% incidence) compared to BID dosing, particularly in younger children, though most cases are non-serious and reversible 6
  • Evaluate clinical response within 48-72 hours of initiating therapy to determine if alternative management is needed 1

Severe Infections Requiring Dose Adjustment

For severe infections in children >3 months, increase dosing frequency to four times daily when using intravenous formulations (30 mg/kg four times daily IV). 1 However, for oral TDS dosing, simply increase the total daily dose rather than frequency (e.g., 40 mg/kg/day instead of 20 mg/kg/day, still divided TDS). 1

References

Guideline

Amoxicillin-Clavulanate Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Development of a twice daily dosing regimen of amoxicillin/clavulanate.

International journal of antimicrobial agents, 2007

Guideline

Pediatric Omeprazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.